- Alzheimer’s Disease is a devastating disease for patients, their families, and the community.
- 5.0% of people aged 65 to 74, 13.1% of people aged 75 to 84, and 33.2% of people aged 85 and older have Alzheimer’s dementia.
- Early detection/diagnosis with a simple blood test opens up the opportunity for new treatments such as lecanemab and pipeline products such as the repurposed drugs discovered by our team. These drugs need a test as a companion diagnostic.
- Effective monitoring of the disease is crucial for treatment, speeding up drug development and regulatory approval otherwise effective treatment may take years to demonstrate.
Pinpoint Molecular Ltd are working on a simple...
Pinpoint Molecular Ltd is using our unique resin...
PCR machines can be classified according to the...